Prucalopride in treatment of functional chronic constipation

The aim of review. To carry out analysis of literature devoted to efficacy assessment of new prokinetic drug – 5-НТ4-receptor agonist prucalopride in treatment of patients with chronic functional constipation.Original points. Being an agonist of 5-НТ4- receptors, prucalopride stimulates motility of...

Full description

Saved in:
Bibliographic Details
Main Author: A. A. Sheptulin
Format: Article
Language:Russian
Published: Gastro LLC 2012-02-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1255
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860199956414464
author A. A. Sheptulin
author_facet A. A. Sheptulin
author_sort A. A. Sheptulin
collection DOAJ
description The aim of review. To carry out analysis of literature devoted to efficacy assessment of new prokinetic drug – 5-НТ4-receptor agonist prucalopride in treatment of patients with chronic functional constipation.Original points. Being an agonist of 5-НТ4- receptors, prucalopride stimulates motility of the large intestine and promotes more frequent bowel movements. Numerous studies confirmed that on a background of prucalopride intake in a dose of 2 or 4 mg for 4-12 wks in patients with chronic constipation defecation frequency increases and quality of life improves. It is important, that the agent has no cardiotoxic effect and does not increase the length of Q–T interval.Conclusion. Prucalopride can be recommended for treatment of functional chronic constipation, first of all – in women, resistant to laxatives.
format Article
id doaj-art-6bd218606c854b64a04abbe318081dcc
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2012-02-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-6bd218606c854b64a04abbe318081dcc2025-02-10T16:14:31ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732012-02-01221913836Prucalopride in treatment of functional chronic constipationA. A. Sheptulin0ГБОУ ВПО ПМГМУ им. И.М. Сеченова РосздраваThe aim of review. To carry out analysis of literature devoted to efficacy assessment of new prokinetic drug – 5-НТ4-receptor agonist prucalopride in treatment of patients with chronic functional constipation.Original points. Being an agonist of 5-НТ4- receptors, prucalopride stimulates motility of the large intestine and promotes more frequent bowel movements. Numerous studies confirmed that on a background of prucalopride intake in a dose of 2 or 4 mg for 4-12 wks in patients with chronic constipation defecation frequency increases and quality of life improves. It is important, that the agent has no cardiotoxic effect and does not increase the length of Q–T interval.Conclusion. Prucalopride can be recommended for treatment of functional chronic constipation, first of all – in women, resistant to laxatives.https://www.gastro-j.ru/jour/article/view/1255chronic constipationslaxative resistanceprucalopride
spellingShingle A. A. Sheptulin
Prucalopride in treatment of functional chronic constipation
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
chronic constipations
laxative resistance
prucalopride
title Prucalopride in treatment of functional chronic constipation
title_full Prucalopride in treatment of functional chronic constipation
title_fullStr Prucalopride in treatment of functional chronic constipation
title_full_unstemmed Prucalopride in treatment of functional chronic constipation
title_short Prucalopride in treatment of functional chronic constipation
title_sort prucalopride in treatment of functional chronic constipation
topic chronic constipations
laxative resistance
prucalopride
url https://www.gastro-j.ru/jour/article/view/1255
work_keys_str_mv AT aasheptulin prucaloprideintreatmentoffunctionalchronicconstipation